29 results
DEFR14A
npjo8 ias45u8uj35
12 May 22
Revised proxy
5:00pm
8-K
EX-99.1
xyppjnqy98hqas0215
9 May 22
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
4:20pm
8-K
EX-99.1
z597cu7l3
20 Apr 22
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
5:24pm
8-K
EX-1.1
4blaxayvkgypop3
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
347j6b
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am